Nexium is AstraZeneca’s top-seller, bringing in $3.8 billion in revenue in 2004. Ranbaxy wants to produce cheap forms of Nexium in 20-and 40-milligram capsule forms. AstraZeneca is already fighting a ...
Option to swallow an oral suspension of Nexium or to have it administered via a stomach tube now availble. AstraZeneca’s Nexium For Delayed-Release Oral Suspension has been approved for the treatment ...
Glenmark has received The Food & Drug Administration’s permission for esomeprazole magnesium delayed-release capsules, 20 mg (OTC), which is the generic of Haleon’s Nexium 24 HR Delayed-Release ...
* Reached settlement of patent litigation with Astrazeneca allowing store brand OTC equivalent of Nexium 24hr capsules to launch in late Sept. Source text for Eikon: Further company coverage: ...
Los Angeles, CA - – A new clinical study shows that the proton pump inhibitor (PPI) NEXIUM® (esomeprazole magnesium) maintained normal gastric (stomach) acid levels in patients with Zollinger-Ellison ...
The Food and Drug Administration has approved use of the drug Nexium in children aged 1 to 11 who have acid reflux disease. FDA said Thursday it approved liquid and delayed-release capsules of Nexium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results